Ofloglee OZ Tablet is a combination medication that features ofloxacin (200 mg) and ornidazole (500 mg) in each tablet. This synergistic formulation harnesses the antibacterial properties of ofloxacin, a fluoroquinolone antibiotic, alongside the antiprotozoal action of ornidazole. Together, they effectively target a wide range of bacterial and protozoal infections, making Ofloglee OZ a versatile choice in treating various conditions.
This medication is particularly indicated for the treatment of infections caused by susceptible strains of bacteria and protozoa, including gastrointestinal infections, urinary tract infections, and certain types of sexually transmitted infections. The dual action of the components allows for a broader spectrum of effectiveness, ensuring that patients receive comprehensive care for their infections.
When using Ofloglee OZ, patients may experience some side effects, which can include nausea, headache, dizziness, or abdominal discomfort. While most side effects are mild and transient, it is essential for patients to be aware of any unusual reactions and consult their healthcare provider if they occur.
For optimal effectiveness, Ofloglee OZ should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Proper storage ensures the stability and efficacy of the medication until its expiration date.